<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               2 DOSAGE AND ADMINISTRATION<BR>               <BR>               <BR>                  <BR>                     <BR>                        <BR>                           4 mg capsules taken orally once daily with water and swallowed whole. (2.1)<BR>                           2 mg capsules taken orally once daily with water and swallowed whole in the presence of: <BR>                                 mild to moderate hepatic impairment (Child-Pugh class A or B) (2.2)<BR>                                 severe renal impairment [Creatinine Clearance (CCr) 10–30 mL/min] (2.2)<BR>                                 drugs that are potent CYP3A4 inhibitors. (2.2)<BR>                              <BR>                           <BR>                           DETROL LA is not recommended for use in patients with CCr <10 mL/min. (2.2)<BR>                           Detrol LA is not recommended for use in patients with severe hepatic impairment (Child-Pugh Class C) (2.2)<BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     2.1 Dosing Information<BR>                     <BR>                        The recommended dose of DETROL LA Capsules is 4 mg once daily with water and swallowed whole.. The dose may be lowered to 2 mg daily based on individual response and tolerability; however, limited efficacy data are available for DETROL LA 2 mg [see <BR>                                 CLINICAL STUDIES (14)<BR>                              <BR>                           ].<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     2.2 Dosage Adjustment in Specific Populations<BR>                     <BR>                        For patients with mild to moderate hepatic impairment (Child-Pugh Class A or B) or severe renal impairment (CCr 10 – 30 mL/min), the recommended dose of DETROL LA is 2 mg once daily. DETROL LA is not recommended for use in patients with severe hepatic impairment (Child-Pugh Class C). Patients with CCr<10 mL/min have not been studied and use of DETROL LA in this population is not recommended [see <BR>                                 WARNINGS AND PRECAUTIONS (5.4)<BR>                              , <BR>                                 USE IN SPECIFIC POPULATIONS (8.6, 8.7)<BR>                              ].<BR>                        <BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     2.3 Dosage Adjustment in Presence of Concomitant Drugs<BR>                     <BR>                        For patients who are taking drugs that are potent inhibitors of CYP3A4 [e.g. ketoconazole, clarithromycin, ritonavir], the recommended dose of DETROL LA is 2 mg once daily [see <BR>                              <BR>                                 DRUG INTERACTIONS (7.2)<BR>                              <BR>                           <BR>                           ].<BR>                        <BR>                     <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>